Seegene Revenue vs. Current Valuation
| 096530 Stock | KRW 23,750 150.00 0.63% |
For Seegene profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Seegene to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Seegene utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Seegene's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Seegene over time as well as its relative position and ranking within its peers.
Seegene |
Seegene Current Valuation vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Seegene's current stock value. Our valuation model uses many indicators to compare Seegene value to that of its competitors to determine the firm's financial worth. Seegene is the top company in revenue category among its peers. It also is the top company in current valuation category among its peers reporting about 2.56 of Current Valuation per Revenue. Comparative valuation analysis is a catch-all model that can be used if you cannot value Seegene by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Seegene's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Seegene Revenue vs. Competition
Seegene is the top company in revenue category among its peers. Market size based on revenue of Health Care industry is presently estimated at about 1.56 Trillion. Seegene totals roughly 1.37 Trillion in revenue claiming about 88% of equities under Health Care industry.
Seegene Current Valuation vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Seegene |
| = | 1.37 T |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Seegene |
| = | 3.51 T |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Seegene Current Valuation vs Competition
Seegene is the top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is presently estimated at about 4.5 Trillion. Seegene totals roughly 3.51 Trillion in current valuation claiming about 78% of equities under Health Care industry.
Seegene Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Seegene, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Seegene will eventually generate negative long term returns. The profitability progress is the general direction of Seegene's change in net profit over the period of time. It can combine multiple indicators of Seegene, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Seegene, Inc. manufactures and sells molecular diagnostics systems. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea. SEEGENE is traded on Korean Securities Dealers Automated Quotations in South Korea.
Seegene Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Seegene. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Seegene position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Seegene's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Seegene without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
| All Next | Launch Module |
Use Investing Themes to Complement your Seegene position
In addition to having Seegene in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Aggressive Funds Thematic Idea Now
Aggressive Funds
Funds or Etfs that attempt to achieve high capital gains by investing in companies with high growth potential and above average risk. The Aggressive Funds theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aggressive Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Seegene Stock
To fully project Seegene's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Seegene at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Seegene's income statement, its balance sheet, and the statement of cash flows.